Le syndrome de l’œil sec, une pathologie en forte progression

Dry eye syndrome is a multifactorial disorder. Although it appears to be benign, it can lead to serious damage to the ocular structure, which alters the vision and quality of life of patients. This disease, which is among the most common in ophthalmology, has increased significantly with the widespr...

Descripción completa

Detalles Bibliográficos
Autor principal: Sergheraert, Laurence
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Masson SAS. 2022
Materias:
Pratique
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8808765/
https://www.ncbi.nlm.nih.gov/pubmed/35125634
http://dx.doi.org/10.1016/j.actpha.2021.12.024
_version_ 1784643912207433728
author Sergheraert, Laurence
author_facet Sergheraert, Laurence
author_sort Sergheraert, Laurence
collection PubMed
description Dry eye syndrome is a multifactorial disorder. Although it appears to be benign, it can lead to serious damage to the ocular structure, which alters the vision and quality of life of patients. This disease, which is among the most common in ophthalmology, has increased significantly with the widespread use of masks during the Covid-19 pandemic.
format Online
Article
Text
id pubmed-8808765
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Masson SAS.
record_format MEDLINE/PubMed
spelling pubmed-88087652022-02-02 Le syndrome de l’œil sec, une pathologie en forte progression Sergheraert, Laurence Actual Pharm Pratique Dry eye syndrome is a multifactorial disorder. Although it appears to be benign, it can lead to serious damage to the ocular structure, which alters the vision and quality of life of patients. This disease, which is among the most common in ophthalmology, has increased significantly with the widespread use of masks during the Covid-19 pandemic. Elsevier Masson SAS. 2022-02 2022-02-02 /pmc/articles/PMC8808765/ /pubmed/35125634 http://dx.doi.org/10.1016/j.actpha.2021.12.024 Text en © 2021 Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Pratique
Sergheraert, Laurence
Le syndrome de l’œil sec, une pathologie en forte progression
title Le syndrome de l’œil sec, une pathologie en forte progression
title_full Le syndrome de l’œil sec, une pathologie en forte progression
title_fullStr Le syndrome de l’œil sec, une pathologie en forte progression
title_full_unstemmed Le syndrome de l’œil sec, une pathologie en forte progression
title_short Le syndrome de l’œil sec, une pathologie en forte progression
title_sort le syndrome de l’œil sec, une pathologie en forte progression
topic Pratique
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8808765/
https://www.ncbi.nlm.nih.gov/pubmed/35125634
http://dx.doi.org/10.1016/j.actpha.2021.12.024
work_keys_str_mv AT sergheraertlaurence lesyndromedelœilsecunepathologieenforteprogression

Ejemplares similares